PhRMA CEO Meets With Wyden Amid Senate Finance Negotiations

By Rachel Cohrs
July 10, 2019 at 4:50 PM
Pharmaceutical Research and Manufacturers of America CEO Stephen Ubl met with Senate Finance Committee ranking Democrat Ron Wyden Tuesday (July 9) as the committee negotiates key components of drug-pricing legislation. Wyden is pushing a Part D provision that would force drug makers to pay back Medicare when prices rise faster than inflation. “I’m in the process of regulating pharmaceutical industry to reduce prescription drug prices. People come in and want to be heard,” Wyden told Inside Drug Pricing . PhRMA...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.